Humira becomes first treatment of hidradenitis suppurativa in Japan

The Japanese regulatory authority has approved mega-blockbuster drug Humira (adalimumab) for the treatment of hidradenitis suppurativa (HS).

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *